139 related articles for article (PubMed ID: 2724143)
1. Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
Duff HJ
J Pharmacol Exp Ther; 1989 May; 249(2):617-22. PubMed ID: 2724143
[TBL] [Abstract][Full Text] [Related]
2. Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacy.
Duff HJ; Mitchell LB; Wyse DG; Gillis AM; Sheldon RS
Clin Invest Med; 1991 Oct; 14(5):476-83. PubMed ID: 1660369
[TBL] [Abstract][Full Text] [Related]
3. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
Duff HJ; Gault NJ
J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
[TBL] [Abstract][Full Text] [Related]
4. Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.
Duff HJ; Rahmberg M; Sheldon RS
J Cardiovasc Pharmacol; 1990 Nov; 16(5):685-92. PubMed ID: 1703588
[TBL] [Abstract][Full Text] [Related]
5. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
Costard-Jäckle A; Franz MR
J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
[TBL] [Abstract][Full Text] [Related]
6. Mexiletine-quinidine in isolated hearts: an interaction involving the sodium channel.
Duff HJ; Cannon NJ; Sheldon RS
Cardiovasc Res; 1989 Jul; 23(7):584-92. PubMed ID: 2557155
[TBL] [Abstract][Full Text] [Related]
7. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
Roden DM; Iansmith DH; Woosley RL
J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
[TBL] [Abstract][Full Text] [Related]
8. Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia.
Sheldon RS; Rahmberg M; Duff HJ
J Cardiovasc Pharmacol; 1990 Nov; 16(5):818-23. PubMed ID: 1703606
[TBL] [Abstract][Full Text] [Related]
9. Electropharmacologic synergism with mexiletine and quinidine.
Duff HJ; Kolodgie FD; Roden DM; Woosley RL
J Cardiovasc Pharmacol; 1986; 8(4):840-6. PubMed ID: 2427827
[TBL] [Abstract][Full Text] [Related]
10. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
11. Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans.
Duff HJ; Mitchell LB; Manyari D; Wyse DG
J Am Coll Cardiol; 1987 Nov; 10(5):1149-56. PubMed ID: 3668109
[TBL] [Abstract][Full Text] [Related]
12. Proarrhythmia of a class Ic drug: suppression by combination with a drug prolonging repolarization in the dog late after infarction.
Duff HJ; Stemler M; Thannhauser T; Laganiere S; Rude E; Lester W
J Pharmacol Exp Ther; 1995 Jul; 274(1):508-15. PubMed ID: 7616438
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study.
Gelzer AR; Kraus MS; Rishniw M; Hemsley SA; Moïse NS
J Vet Cardiol; 2010 Aug; 12(2):93-106. PubMed ID: 20663731
[TBL] [Abstract][Full Text] [Related]
15. Ventricular electrophysiology of quinidine-propranolol combinations in the dog heart.
Korte DW; Nash CB
J Pharmacol Exp Ther; 1976 May; 197(2):452-7. PubMed ID: 1271287
[TBL] [Abstract][Full Text] [Related]
16. Combination drug therapy for ventricular arrhythmias.
Krichbaum DW
Clin Pharm; 1988 Nov; 7(11):808-19. PubMed ID: 3058377
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
[TBL] [Abstract][Full Text] [Related]
18. Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
Monk JP; Brogden RN
Drugs; 1990 Sep; 40(3):374-411. PubMed ID: 2226221
[TBL] [Abstract][Full Text] [Related]
19. Quinidine for ventricular arrhythmias: value of electrophysiologic testing.
DiMarco JP; Garan H; Ruskin JN
Am J Cardiol; 1983 Jan; 51(1):90-5. PubMed ID: 6849270
[TBL] [Abstract][Full Text] [Related]
20. Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo.
Costard-Jaeckle A; Liem LB; Franz MR
J Cardiovasc Pharmacol; 1989 Dec; 14(6):810-7. PubMed ID: 2481766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]